Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CARDIAC TROPONIN INDUSTRY
2.1 Summary about Cardiac Troponin Industry
2.2 Cardiac Troponin Market Trends
2.2.1 Cardiac Troponin Production & Consumption Trends
2.2.2 Cardiac Troponin Demand Structure Trends
2.3 Cardiac Troponin Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Laboratory Testing
4.2.2 Point-of-care Testing
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Acute Coronary Syndrome
4.3.2 Myocardial Infarction
4.3.3 Congestive Heart Failure
4.3.4 Others Applications
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Laboratory Testing
5.2.2 Point-of-care Testing
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Acute Coronary Syndrome
5.3.2 Myocardial Infarction
5.3.3 Congestive Heart Failure
5.3.4 Others Applications
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Laboratory Testing
6.2.2 Point-of-care Testing
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Acute Coronary Syndrome
6.3.2 Myocardial Infarction
6.3.3 Congestive Heart Failure
6.3.4 Others Applications
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Laboratory Testing
7.2.2 Point-of-care Testing
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Acute Coronary Syndrome
7.3.2 Myocardial Infarction
7.3.3 Congestive Heart Failure
7.3.4 Others Applications
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Laboratory Testing
8.2.2 Point-of-care Testing
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Acute Coronary Syndrome
8.3.2 Myocardial Infarction
8.3.3 Congestive Heart Failure
8.3.4 Others Applications
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Laboratory Testing
9.2.2 Point-of-care Testing
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Acute Coronary Syndrome
9.3.2 Myocardial Infarction
9.3.3 Congestive Heart Failure
9.3.4 Others Applications
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Abbott Diagnostics
10.1.2 Roche
10.1.3 bioMrieux
10.1.4 BG Medicine
10.1.5 Ortho Clinical Diagnostics
10.1.6 Singulex
10.1.7 Alere
10.1.8 Siemens Healthcare Diagnostics
10.1.9 Beckman Coulter
10.1.10 LifeSign
10.2 Cardiac Troponin Sales Date of Major Players (2017-2020e)
10.2.1 Abbott Diagnostics
10.2.2 Roche
10.2.3 bioMrieux
10.2.4 BG Medicine
10.2.5 Ortho Clinical Diagnostics
10.2.6 Singulex
10.2.7 Alere
10.2.8 Siemens Healthcare Diagnostics
10.2.9 Beckman Coulter
10.2.10 LifeSign
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Cardiac Troponin Product Type Overview
Table Cardiac Troponin Product Type Market Share List
Table Cardiac Troponin Product Type of Major Players
Table Brief Introduction of Abbott Diagnostics
Table Brief Introduction of Roche
Table Brief Introduction of bioMrieux
Table Brief Introduction of BG Medicine
Table Brief Introduction of Ortho Clinical Diagnostics
Table Brief Introduction of Singulex
Table Brief Introduction of Alere
Table Brief Introduction of Siemens Healthcare Diagnostics
Table Brief Introduction of Beckman Coulter
Table Brief Introduction of LifeSign
Table Products & Services of Abbott Diagnostics
Table Products & Services of Roche
Table Products & Services of bioMrieux
Table Products & Services of BG Medicine
Table Products & Services of Ortho Clinical Diagnostics
Table Products & Services of Singulex
Table Products & Services of Alere
Table Products & Services of Siemens Healthcare Diagnostics
Table Products & Services of Beckman Coulter
Table Products & Services of LifeSign
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Cardiac Troponin Market Forecast (Million USD) by Region 2021f-2026f
Table Global Cardiac Troponin Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Cardiac Troponin Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Cardiac Troponin Market Forecast (Million USD) Share by Demand 2021f-2026f